Sintx Technologies SINT
NASDAQ SINT
$1.57 -0.02 (-1.26%)
At close: Aug 20, 2026 · 2:22 PM UTC

Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018)

Sintx Technologies (SINT) posted quarterly Cash from Discontinued Operations of 882000.0 for Q4 2018, down 47.84% year-over-year from 1691000.0 in Q4 2017, and up 352.31% quarter-over-quarter from 195000.0 in Q3 2018.

Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018) Analysis & Trends

Sintx Technologies' Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 882000.0 for Q4 2018.

  • In Q4 2018, Cash from Discontinued Operations fell 47.84% year-over-year to 882000.0; the TTM figure through Dec 2018 stood at 675000.0 (changed N/A YoY), while the FY2018 annual figure was 675000.0, down 72.42% from the prior year.
  • Cash from Discontinued Operations for Q4 2018 stood at 882000.0, up from 195000.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 1691000.0 in Q4 2017, with the low at 616000.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn -
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn -
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn -
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn -
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn -
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn -
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn -
10 Sintx Technologies 7.61 Mn 7.61 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 882,000.00
Dec 31, 2018 882,000.00
Sep 30, 2018 195,000.00
Sep 30, 2018 195,000.00
Jun 30, 2018 -616,000.00
Jun 30, 2018 -616,000.00
Mar 31, 2018 214,000.00
Mar 31, 2018 214,000.00
Dec 31, 2017 1.69 Mn
Dec 31, 2017 1.69 Mn